We work with innovators of biotech, healthcare, science, sustainability, and advanced technology
San Jose's new biotech incubator: BioCube North
With BioCube’s cool wet labs now up and running, the next wave of budding biotech companies have a good reason to locate closer to San Jose.
AIStorm snags $16M Series B to add AI to tiny sensors
AI-in-Sensor specialist AIStorm closed out 2020 with $16M extra in the bank. After its $13.2M Series A announcement and product news in early 2019, the company has been focused on building customers and strategic partners. 2021 promises to be a big year.
Jifflenow helps marketers optimize their event marketing ROI
With all trade shows and marketing events now taking place virtually, attendee engagement at virtual events has become a major challenge for marketers. Jifflenow has the solution.
CureLab Oncology receives pre-IND response from the FDA
The pre-IND briefing package was centered around a proposed Phase II US clinical trial for CureLab’s experimental cancer-fighting DNA vaccine.
CureLab expands team and presence to accelerate clinical trials
CureLab is developing an investigational DNA vaccine called Elenagen, which reverses tumor grade, changes tumor microenvironment, and stimulates an immune attack on the tumor.
Bioinsider Friday Roundtables Focus on COVID-19 Immunogenicity, Drug Shortages, and Clinical Trials
ZingPR and Bioinsider convene biotech experts to network, exchange ideas and address timely issues in science and healthcare.
Transform Materials converts natural gas into hydrogen and acetylene
At hydraulic fracking wellheads, natural gas is often flared instead of collected—a colossal waste of a natural resource that increases harmful greenhouse gases.
Highlights from Bioinsider’s Therapeutic Pipeline for COVID-19 Virtual Meeting
The Therapeutic Pipeline for COVID-19 meeting was the second in Bioinsider’s ‘Together as One’ COVID-19 Virtual Meeting Series. It brought together more than 100 researchers and featured 11 keynote presentations focused on small-molecule and antibody-based approaches. Here’s what we learned.
Biovista's AI identifies two more drugs for treating COVID-19
Biovista applies AI and data science to identify two drugs as potentially effective therapies for blood clots and inflammation caused by COVID-19. That’s six treatments identified to date!
Could junk DNA be a key to unlock biocomputing?
Our genome may be far smarter than everyone previously believed. Could the many ‘junk’ DNA repeat elements provide the foundation for building a novel type of biocomputer?
ZingPR teams with Bioinsider to promote COVID-19 virtual meetings
Bioinsider, the leading virtual meeting platform for communication among the scientific, policymaker, and business communities, is partnering with ZingPR for media relations and speaker promotion.
AAPM seeks innovative medical breakthroughs against COVID-19 in the race to save lives
The AAPM facilitates a dialogue between the ‘4 Ps‘ of precision medicine: patients, providers, public health planners, and payers to work together to achieve the goal of delivering improved outcomes at reduced costs.
Why coffee berry borer beetles hate Crop Enhancement
This nasty little pest makes life difficult for coffee growers. But now they can fight back with Crop Enhancement’s new technology.
Mana Monitoring sets a course for the mainland
An energy-management services startup in “stealth” for five years, Maui-based Mana Monitoring has successfully acquired customers in Hawaii and mainland U.S. CEO Zoltan Milaskey recently retained ZingPR to put his company on the national news map. But first, how about some local news coverage?
Crop Enhancement secures investment from Cavallo Ventures
Cavallo Ventures, the venture capital arm of Wilbur-Ellis, has invested in ZingPR client Crop Enhancement. With its investment, Cavallo Ventures aims to accelerate the development of Crop Enhancement's breakthrough crop protection technology in the United States — particularly for the production of high-value fruit and vegetable crops.
Cardax launches clinical trial for anti-inflammatory ZanthoSyn
ZingPR is working with Hawaii-based Cardax to boost awareness about its breakthrough anti-inflammatory, which is made from naturally occurring algae.